Squarepoint Ops LLC Shattuck Labs, Inc. Transaction History

Squarepoint Ops LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$3.56 - $11.18 $36,906 - $115,903	-10,367 Reduced 17.77%	47,975 $185,000
Q1 2024 May 15, 2024	BUY	$7.37 - $10.09 $429,980 - $588,670	58,342 New	58,342 $521,000
Q2 2023 Aug 14, 2023	BUY	$2.52 - $3.66 $8,237 - $11,964	3,269 Added 31.52%	13,640 $42,000
Q1 2023 May 15, 2023	BUY	$2.5 - $4.72 $25,927 - $48,951	10,371 New	10,371 $30,000
Q1 2022 May 16, 2022	SELL	$4.22 - $8.89 $139,441 - $293,752	-33,043 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.36 - $21.08 $276,239 - $696,546	33,043 New	33,043 $281,000

28.8M

300

1.2K

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $46.6M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.